My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Organon & Co. Common Stock (NY:OGN)

5.800 +0.100 (+1.75%)

Streaming Delayed Price Updated: 11:45 AM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Organon & Co. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Gold Falls 3%; Carter's Shares Gain After Q3 Earnings ↗

October 27, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

October 27, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

These stocks are moving in today's pre-market session ↗

October 27, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

A Look Ahead: Organon's Earnings Forecast ↗

August 04, 2025

Via Benzinga

Organon CEO Kevin Ali Resigns Amid Audit Probe Into Wholesaler Sales Practices ↗

October 27, 2025

Organon said that the investigation found that certain wholesalers in the United States were asked to buy more Nexplanon than they needed.

Via Stocktwits

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

Organon Appoints Company Executive Joseph Morrissey as Interim CEO and Board Chair Carrie Cox as Executive Chair; Announces Results of Audit Committee Investigation

October 27, 2025

From Organon

Via Business Wire

3 Small-Cap Stocks We Steer Clear Of

October 21, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

1 Profitable Stock Worth Your Attention and 2 Facing Challenges

October 16, 2025

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Via StockStory

DexCom, Masimo, Integer Holdings, The Pennant Group, and Organon Stocks Trade Down, What You Need To Know

October 10, 2025

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Via StockStory

Q2 Earnings Highs And Lows: Organon (NYSE:OGN) Vs The Rest Of The Branded Pharmaceuticals Stocks

October 08, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Organon (NYSE:OGN) and the best and worst...

Via StockStory

Topics Artificial Intelligence Intellectual Property

3 Reasons to Avoid OGN and 1 Stock to Buy Instead

October 06, 2025

Over the past six months, Organon’s shares (currently trading at $11.05) have posted a disappointing 11.7% loss, well below the S&P 500’s 32.7% gain. This may have investors wondering how to approach...

Via StockStory

Topics Government Stocks World Trade

Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement

September 30, 2025

New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a...

Via MarketMinute

Topics Government

Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge

September 30, 2025

Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing...

Via MarketMinute

Topics Economy Government World Trade

AbbVie, AMN Healthcare Services, LeMaitre, Waters Corporation, and Organon Shares Skyrocket, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.

Via StockStory

Topics Government

1 Surging Stock Worth Your Attention and 2 We Avoid

September 29, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

Topics Initial Public Offering

Johnson & Johnson's Hypothetical Rally: A Look at Potential 2025 Valuation Drivers

September 27, 2025

In a hypothetical scenario playing out just last week, leading up to September 27, 2025, Johnson & Johnson (NYSE: JNJ) experienced a significant stock rally, capturing the attention of investors and...

Via MarketMinute

Topics Economy Intellectual Property

Why Organon (OGN) Stock Is Trading Up Today

September 11, 2025

Shares of pharmaceutical company Organon (NYSE:OGN) jumped 2.1% in the morning session after the stock extended its positive momentum as the U.S. Food and Drug Administration (FDA) approved its two...

Via StockStory

Topics Artificial Intelligence Economy Initial Public Offering

3 Stocks Under $50 We Find Risky

September 11, 2025

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and...

Via StockStory

US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively

September 02, 2025

From Organon & Co.

Via Business Wire

3 Cash-Producing Stocks with Warning Signs

August 28, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

1 Healthcare Stock Worth Investigating and 2 Facing Challenges

August 20, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Artificial Intelligence Economy

OGN Q2 Deep Dive: Flat Sales, Margin Pressure, and Strategic Shifts Highlight Quarter

August 13, 2025

Pharmaceutical company Organon (NYSE:OGN) beat Wall Street’s revenue expectations in Q2 CY2025, but sales were flat year on year at $1.59 billion. The company expects the full year’s revenue to be...

Via StockStory

3 of Wall Street’s Favorite Stocks We Find Risky

August 11, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Organon (OGN) Fiscal Q2 Revenue Beats 1% ↗

August 06, 2025

Via The Motley Fool

Organon (NYSE:OGN) Surprises With Q2 Sales, Stock Soars

August 05, 2025

Pharmaceutical company Organon (NYSE:OGN) reported Q2 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $1.59 billion. The company expects the full year’s...

Via StockStory

Organon Reports Results for the Second Quarter Ended June 30, 2025

August 05, 2025

From Organon & Co.

Via Business Wire

Organon Earnings: What To Look For From OGN

August 03, 2025

Pharmaceutical company Organon (NYSE:OGN) will be reporting earnings this Tuesday before market hours. Here’s what you need to know.

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9

...

18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.